IP Library › Granted Patent US 8,486,662
Granted Patent B2
US 8,486,662 · App. 13/288,260 · Granted Jul 16, 2013

DNA encoding antibody molecules having specificity for human IL-6

Inventors: Richard Evan Gelinas (Seattle, WA); Mitra Choudhury Singhal (Seattle, WA); Yi Zhang (Palo Alto, CA); Andrew George Popplewell (Slough, GB); Ralph Adams (Slough, GB)
Assignee: UCB Pharma S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,486,662
App. No.
13/288,260
Granted
Jul 16, 2013
Kind
B2
Abstract

The invention relates to antibody molecules having specificity for antigenic determinants of IL-6, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Claims (15)

1. An isolated DNA encoding a light chain, a heavy chain, or both a light chain and a heavy chain, of a neutralizing antibody having specificity for human IL-6, wherein the variable domain of the light chain comprises the amino acid sequences given in SEQ ID NO:8 for CDR-L1, SEQ ID NO:9 for CDR-L2 and SEQ ID NO:10 for CDR-L3, and the variable domain of the heavy chain comprises the amino acid sequences given in SEQ ID NO:5 for CDR-H1, in SEQ ID NO:6 for CDR-H2 and SEQ ID NO:7 for CDR-H3.

2. An isolated DNA encoding a heavy chain, a light chain, or both a heavy chain and a light chain, of an antibody having specificity for human IL-6, wherein the heavy chain comprises the amino acid sequence gH13 (SEQ ID NO:11), and the light chain comprises the amino acid sequence gL10 (SEQ ID NO:13.

3. The isolated DNA according to claim 2 in which the DNA sequence encoding the heavy chain comprises the sequence given in SEQ ID NO:12 or SEQ ID NO:15 or nucleotides 58-2008 of SEQ ID NO:15.

4. The isolated DNA according to claim 2 in which the DNA sequence encoding the light chain comprises the sequence given in SEQ ID NO:14 or SEQ ID NO:17 or nucleotides 61-705 of SEQ ID NO:17.

5. A cloning or expression vector comprising a DNA according to claim 2 .

6. The vector according to claim 5 , wherein the vector comprises the sequence given in SEQ ID NO:12 and the sequence given in SEQ ID NO:14.

7. A cultured host cell comprising a cloning or expression vector according to claim 5 .

8. A process for the production of an antibody, which has specificity for human IL-6 and comprises the heavy chain variable domain of SEQ ID NO:11 and the light chain variable domain of SEQ ID NO:13, comprising culturing a host cell containing an expression vector or vectors comprising DNA encoding said heavy and light chain variable domains under conditions suitable for the expression of the antibody; and isolating the antibody.

9. An isolated DNA encoding a heavy chain, a light chain, or both a heavy chain and a light chain, of a neutralising antibody having specificity for human IL-6, wherein the heavy chain comprises the amino acid sequence given in SEQ ID NO:16, and the light chain comprises the amino acid sequence given in SEQ ID NO:18.

10. The isolated DNA according to claim 9 in which the DNA sequence encoding the heavy chain comprises the sequence given in SEQ ID NO:12 or SEQ ID NO:15 or nucleotides 58-2008 of SEQ ID NO:15.

11. The isolated DNA according to claim 9 in which the DNA sequence encoding the light chain comprises the sequence given in SEQ ID NO:14 or SEQ ID NO:17 or nucleotides 61-705 of SEQ ID NO:17.

12. A cloning or expression vector comprising a DNA according to claim 9 .

13. The vector according to claim 12 , wherein the vector comprises the sequence given in SEQ ID NO:15 and the sequence given in SEQ ID NO:17.

14. A cultured host cell comprising a cloning or expression vector according to claim 12 .

15. A process for the production of an antibody, which has specificity for human IL-6 and comprises the heavy chain of SEQ ID NO:16 and the light chain of SEQ ID NO:18, comprising culturing a host cell containing an expression vector or vectors comprising DNA encoding said heavy and light chains under conditions suitable for the expression of the antibody; and isolating the antibody.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2022
From: UCB PHARMA SA
To: R-PHARM INTERNATIONAL LLC
Reel/Frame 059151/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2012
From: GELINAS, RICHARD EVANS; SINGHAL, MITRA CHOUDHURY; ZHANG, YI; POPPLEWELL, ANDREW GEORGE; ADAMS, RALPH
To: UCB S.A.
Reel/Frame 028257/0880 →
CONFIRMATORY ASSIGNMENT Recorded May 23, 2012
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 028260/0590 →
Continuity (3)
Division 11608408 · Dec 8, 2006
Provisional Application 60748926 · Dec 9, 2005
Related Publication 20120183996A1 · Jul 19, 2012